Clinical Trials at the University of Florida Proton Therapy Institute
Confidence Through Clinical Research
We believe that, with clinical research, proton therapy will likely become the cancer treatment of choice for many patients. The future of proton therapy depends heavily on clinical research over the coming years. That's why our primary mission is to conduct clinical research to improve the effectiveness and availability of proton therapy.
Most of the studies conducted at the University of Florida Proton Therapy Institute are based on the expectation that at least one outcome of treatment will be significantly better than what can be achieved with traditional radiation therapy.
Proton therapy research will focus on a number of areas and types of cancer, including pediatric malignancies, lymphoma, eye malignancies and disorders, and cancers of the central nervous system, head and neck, breast, pancreas and urological and pulmonary systems – as well as sarcomas.
Current clinical trials:
Click on the below term to jump down to the correlating trial(s)
Breast Cancer
1st Study title:
UFPTI 1016-BR01: Proton Therapy for Peripheral Lymph Nodes in Breast Cancer
Principal Investigator:
Julie Bradley, M.D.
Why is this study being done?
The purpose of this study is to determine if proton radiation therapy will reduce the amount of your heart that is exposed to radiation, thereby decreasing the frequency and/or severity of any cardiac side effects.
Contact us for additional Information on this trial.
Central Nervous System
Study title:
UFPTI 1101- NF01: Spinal Tumor Proton Protocol
Principal Investigator:
Randal Henderson, MD, MBA
Why is this study being done?
The purpose of this study is to determine if Proton Therapy can provide effective and safe treatment for Malignant Peripheral Nerve Sheath Tumors of the spine and Neurofibromas of the spine that are growing or causing symptoms. The study will include adult patients with Neurofibromatosis 1 (NF1). Additional purposes of this study are to see if the rate of developing other types of cancer in the treatment area (second malignancy rate) is lower with the use of protons as compared to conventional radiation, assess the side effects associated with this treatment and the quality of life for patients both during and after treatment.
Contact us for additional Information on this trial.
Study title:
UFPTI 0701-PI01: Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect and analyze the information pertaining to the tumor response and side effects from proton radiation treatment.
Contact us for additional Information on this trial.
Chordomas and/or Chondrosarcomas
Study title:
UFPTI 0607- CH01: A Clinical Outcomes Protocol of Proton Beam Radiation Therapy for Chordomas and/or Chondrosarcomas of the Base of Skull and/or Spine
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect information from your medical records to see what effects the proton beam radiation has on you and your cancer.
Contact us for additional Information on this trial.
Head and Neck Cancer
1st Study title:
UFPTI 0605- NP01: A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Nasopharynx
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton beam radiation has on you and your cancer.
Contact us for additional Information on this trial.
2nd Study title:
UFPTI 0601 - OP01: A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Oropharyngeal Cancers
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton beam radiation has on you and your cancer.
Contact us for additional Information on this trial.
3rd Study title:
UFPTI 0604 - SI01: A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton beam radiation has on you and your cancer.
Contact us for additional Information on this trial.
Lung Cancer
1st Study title:
UFPTI 0802-LU02: A Phase II Trial of 3 Dimensional Proton Radiotherapy with Concomitant Chemotherapy for Patients with Initially Unresectable Stage III Non-Small Cell Lung Cancer
Principal Investigator:
Bradford S. Hoppe, MD
Why is this study being done?
The purpose of this study is to find out what effects, good and/or bad, proton radiation at a higher tumor dose (and lower normal surrounding lung dose) combined with standard chemotherapy has on you and your lung cancer. The dose you receive to the tumor will be higher than the standard dose. This may be able to increase the control of your tumor. Due to the accuracy of radiation given with protons, the dose to the normal lung tissue that surrounds the tumor will be lower than standard. This may be able to reduce the frequency and severity of the usual radiation side effects.
Contact us for additional Information on this trial.
2nd Study title:
UFPTI 0901 - LU03: Hypofractionated, Image-Guided Radiation Therapy with Proton Therapy for Stage I Non-Small Cell Lung Cancer
Principal Investigator:
Bradford S. Hoppe, MD
Why is this study being done?
The purpose of this research study is to determine if hypofractionated image guided radiation therapy (hypoIGRT) is a good way to treat lung tumors for patients who will not have surgery. HypoIGRT is a general term for a group of techniques that deliver higher daily doses of radiation over a shorter period of time compared with conventional radiation. This is thought to be better than conventional radiation, because it delivers a more lethal dose of radiation to the tumor, uses more precise set up that decreases the amount of your lung and heart exposed to radiotherapy, and is more convenient with treatment being completed within 2-3 weeks compared to the typical 7-8 week course of conventional radiotherapy.
Contact us for additional Information on this trial.
3nd Study title:
UFPTI 1116 – LUN005-12: A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Principal Investigator:
Bradford Hoppe, MD, MPH
Why is this study being done?
This study is being done to see if we can develop a more effective and shorter treatment approach for stage III non-small cell lung cancer.
Contact us for additional Information on this trial.
Lymphoma
Study title:
UFPTI 0806 – HL01: Improving the therapeutic ratio by using Proton Beam Radiation Therapy for patients with stage IA-IIIBX (bulky/non-bulky) Hodgkin lymphoma involving the mediastinum following standard chemotherapy
Principal Investigator:
Bradford S. Hoppe, MD
Why is this study being done?
The purpose of this study is to look at the role of proton therapy in reducing treatment related side effects.
Contact us for additional Information on this trial.
Outcome Tracking Project
Study title:
The University of Florida Proton Therapy Institute (UF Proton Therapy Institute) Outcome Tracking Project (OTP) (The UF Proton Therapy Institute OTP)
Principal Investigator:
Nancy P. Mendenhall, MD
Why is this study being done?
The purpose of this study is to collect information from you and your medical records regarding your disease, your treatment, and your side effects to see what effects the radiation has on you and your disease.
Contact us for additional Information on this trial.
Pancreatic Cancer
1st Study title:
UFPTI 0609-PC01: A Study Using Photon/Proton Beam Radiation Therapy and Chemotherapy for Unresectable Carcinoma of the Pancreas
Principal Investigator:
R. Charles Nichols, MD
Why is this study being done?
The purpose of this study is to find out what effects proton radiation and chemotherapy has on you and your pancreatic cancer.
Contact us for additional Information on this trial.
2nd Study title:
UFPTI 0704-PC02: A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
Principal Investigator:
R. Charles Nichols, MD
Why is this study being done?
The purpose of this study is to find out what effects proton radiation combined with chemotherapy and surgery has on you and your pancreatic cancer. This study will look at the side effects from the treatment and the quality of your life in relation to pain. It will also look at how the tumor responds to the combination of treatment with radiation, chemotherapy and surgery.
Contact us for additional Information on this trial.
3nd Study title:
UFPTI 1013-PC03: A Phase II Trial of Postoperative Proton Radiotherapy with Concomitant Chemotherapy for Patients with Resected Pancreatic Adenocarcinoma
Principal Investigator:
R. Charles Nichols, MD
Why is this study being done?
To find out what effects, good and/or bad, proton radiation combined with chemotherapy (Gemzar®) has on you and your resected pancreatic cancer.
Contact us for additional Information on this trial.
Pediatric
1st Study title:
Risk-Adapted Therapy For Children Less Than 3 Years Of Age With Embryonal Brain Tumors, High-Grade Glioma, Choroid Plexus Carcinoma Or Ependymoma (Sjyc07 Protocol)
A joint study conducted by St. Jude Children's Research Hospital and UF Proton Therapy Institute
Principal Investigator:
Daniel J. Indelicato, MD
Why is this study being done?
Radiation therapy is an important part of treatment for brain tumors in children younger than 3 years of age. Past attempts to delay or avoid using radiation therapy in very young children with brain tumors have not been successful. When radiation therapy is not given, the tumor is likely to come back within a year from diagnosis. The goal of delaying radiation therapy was to avoid side effects. Side effects were considered severe in children with medulloblastoma, PNET, ATRT, and similar tumors when the entire brain and spine was treated (craniospinal irradiation). Side effects were of great concern in children with ependymoma and similar tumors even though treatment of only the tumor bed has been the standard. Our recent research protocols suggest that using radiation therapy soon after initial surgery results in better cure rates and that the anticipated side effects are less because newer methods of radiation therapy have been developed.
Contact Annemarie McClellan 901-495-2734 at St Jude Children's Research Hospital for additional Information on this trial
2nd Study title:
UFPTI 0903-CN01: A Study of Late Effects After Proton Radiotherapy for Pediatric Tumors of the Brain, Head, and Neck
Principal Investigator:
Robert B. Marcus, Jr., MD
Why is this study being done?
The purpose of this study is to show a relation between the dose of radiation to normal brain tissue in the child’s brain with late endocrine (pituitary, thyroid, and adrenal glands) effects, auditory (hearing) effects, alopecia (hair loss), and in addition, monitor the quality of life after proton radiation therapy.
Contact us for additional Information on this trial.
3rd Study title:
RT2CR: A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma and Observation for Craniopharyngioma after Radical Resection
Principal Investigator:
Daniel J. Indelicato, MD – local PI
Why is this study being done?
The main goal of this study is to learn if proton radiation therapy will effectively treat patients with craniopharyngioma brain tumors and reduce side effects compared to more traditional forms of radiation therapy.
This study also has several other goals:
- Evaluate and compare the side effects of surgery with proton therapy.
- Study problems with sleep after surgery and/or proton therapy.
- Learn more about physical performance problems in patients with craniopharyngioma.
- Investigate the role of MRI in evaluating the response of the tumor and normal tissue to treatment.
- Determine if PET scans will predict which tumors are more likely to grow back after treatment.
- Evaluate the ability of PET to confirm the limit of proton therapy dose in normal brain tissue.
- Study the changes in cytokines in blood, markers of inflammation and tumor response after treatment.
- Learn more about craniopharyngioma and how it responds to treatment by evaluating tumor tissue and blood.
Contact us for additional Information on this trial.
Prostate Cancer
1st Study title:
UFPTI 0702 - PR04: A Phase II Study of Hypofractionated Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
Principal Investigator:
Randal Henderson, MD
Why is this study being done?
Our purpose in this trial is to give a shorter course (5 1/2 weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
Multiple studies have shown an advantage to higher doses of radiation in the treatment of prostate cancer. Some studies show that a shorter, hypofractionated, course of radiation (total dose of radiation is divided into large doses - for a smaller total dose) can be used to safely deliver an equivalent killing effect on prostate cancer cells. This study will see the effects (good and/or bad) of a 5 ½ week course of hypofractionated image-guided proton radiation on you and your cancer.
Contact us for additional Information on this trial.
2nd Study title:
UFPTI 0703-PR05: A Phase II Study of Proton Based Radiation Therapy with Elective Pelvic Nodal Irradiation, Concomitant Docetaxel, and Adjuvant Androgen Deprivation for High Risk Prostate Adenocarcinoma
Principal Investigator:
Nancy P. Mendenhall, MD
Why is this study being done?
The purpose of this study is to see what effects, good and/or bad, image guided proton based radiation combined with low dose chemotherapy and hormonal therapy has on you and your cancer.
Contact us for additional Information on this trial.
3rd Study title:
UFPTI 0902-PR06: Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy
Principal Investigator:
Randal H. Henderson, MD
Why is this study being done?
The purpose of this study is to evaluate the safety and effectiveness of proton radiation therapy for patients who have undergone radical prostatectomy.
Proton treatment will be given to the prostate bed area in patients at high risk of developing a local recurrence in the future and in patients who have already developed a local recurrence. This will include patients with a rising PSA and no evidence of spread of the cancer elsewhere in the body.
The pelvic lymph nodes will also be treated with conformal x-ray photon treatment in patients who have a high likelihood of cancer involving those nodes.
Some patients may also receive hormone therapy for 2 years, starting 2 months prior to radiation.
Contact us for additional Information on this trial.
4th Study title:
UFPTI 1103-PR07: An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate
Principal Investigator:
Randal Henderson, MD, MBA
Why is this study being done?
Our purpose in this trial is to give a shorter course (5 ½-6 weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
Multiple studies have shown an advantage to higher doses of radiation in the treatment of prostate cancer. Some studies show that a shorter, hypofractionated, course of radiation (radiation delivered with a larger daily dose to a lower total dose) can be used to safely deliver an equivalent killing effect on prostate cancer cells. This study will see the effects (good and/or bad) of a 5 ½-6 week course of hypofractionated image-guided proton radiation on you and your cancer.
Contact us for additional Information on this trial.
Sarcoma
Skin
Study title:
UFPTI 0606- SK01: A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck with Perineural Invasion
Principal Investigator:
Robert Malyapa, MD, PhD
Why is this study being done?
The purpose of this study is to collect information from the questionnaire and your medical records to see what effects the proton beam radiation has on you and your cancer.
Contact us for additional Information on this trial.
University of Florida Proton Therapy Institute
2015 North Jefferson Street | Jacksonville, FL 32206
(877) 686-6009
(904) 588-1800
©2012 University of Florida Proton Therapy Institute.
Affiliated with The University of Florida. All rights reserved.